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Functional mapping of the cell cycle START gene CDC25 has revealed two domains which are dispensable for viability 
(germination and growth in glucose media), but are essential for sporulation and differentially involved in glucose-in- 
duced CAMP signaling. The transient rise of CAMP is completely prevented by various deletions within the amino-tenni- 
nal half (a domain) of the CDC25 gene product. In contrast, the deletion of the carboxy-terminal 38 residues (82 domain) 
results in a rapid, but persisting, rise of CAMP. Our data suggest hat the a domain of the CDC25 protein is involved 
in glucose signal transduction, whereas the gZ domain is required for downregulating the CAMP control chain. 
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1. INTRODUCTION 
Glucose has a hormone-like effect on derepress- 
ed yeast cells: it induces a rapid, transient increase 
of the intracellular CAMP level [l-4]. The CAMP 
signal requires the activity of at least one of the 
three hexose-phosphorylating enzymes hexokinase 
1, hexokinase 2 or glucokinase [5] and the presence 
of wild type ras proteins [6], and it triggers a 
phosphorylation cascade leading to the mobiliza- 
tion of storage carbohydrate, the activation of 
glycolytic enzymes and the inhibition of 
gluconeogenesis [7]. The most upstream function 
of the CAMP control pathway has been shown to 
be coded by the cell division cycle gene CDC25 
[8- 111. The CDC25 protein is required to activate 
ras proteins, probably by catalyzing the GDP-GTP 
exchange reaction [g-12], and in addition is in- 
volved in the decision between mitosis and meiosis 
[13,14]. We have recently identified three func- 
tionally different domains of the CDC25 protein 
by gene disruption and deletion experiments [141. 
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The amino-terminal half (a domain) and the 
carboxy-terminal 38 residues (#2 domain) are re- 
quired for sporulation, but not for growth in 
glucose media, whereas most of the carboxy- 
terminal half (~31 domain) is essential for viability 
in the presence of a wild type CAMP control chain. 
In addition, the (Y domain is required for storage 
carbohydrate mobilization and growth on non- 
fermentable carbon sources. 
In this study we demonstrate that the LY domain 
of the CDC25 protein is also required for glucose- 
induced CAMP signaling, whereas the ,K? domain 
appears to be involved in downregulating the 
CAMP control chain. 
2. MATERIALS AND METHODS 
2.1. Construction of mutant strains 
The construction of strains HK3, HK4, KLl, KM4, KM10 
and KM18 (see table 1) has been described [14,15]. The mutant 
allele cdc25m4 was introduced by deleting a 705 bp HpaI frag- 
ment from plasmid pcdc25-ml [14]. The deletion m5 was per- 
formed by HpaI/BgnI digestion of pcdc25-ml, repair of the 
EglrI single-stranded end and religation. The resulting plasmids 
pcdc2.5-m4 and pcdc25-m5 were then cleaved with SalI and 
PvuII, and the cdc25-containing fragments were introduced in- 
to HK3 by single step replacement. The chromosomal maps of 
the cdc25-m4 and cdc25-m5 alleles were confirmed by genomic 
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Table 1 
Strains used in this study 
HK3 
KLlb 
KM4 
KM10 
KM18 
KM20 
KMZla(b) 
KM22a(b) 
KM23 
KM24 
KM25a(b) 
KM26a(b) 
KM27 
MATa/MATcY ura3/ura3 his31 + leu2/ + 
MATa cdc25-1 ura3 
MATa/MATcu cdc25-dI::URA3/cdc25-dl::URA3 u&/ma3 
his3/ + Ieu2/ + 
MATa/MATcu cdc25-d3::HIS3/cdc25-d3::HIS3 his3/his3 
ura3/ + leu2/ + 
MATa/MATcu cdc25-m2::URA3/cdc25-m2::URA3 ura3/ura3 
his3/+ leu2/+ 
MATa/MATa cdc25-m4:: URA3/ + ura3/ura3 his3/ + leu2/ + 
MATa cdc25-m4::URA3 ura3 his3 
MATa cdc25-m4::URA3 ura3 Ieu2 
MATa/MATo cdc25-m4::URA3/cdc25-m4::URA3 ura3/ura3 
his3/ + leu2/+ 
MATa/MATcu cdc25-mS::URA3/ + ura3/ura3 his31 + leu2/ f 
MATa cdc25-m5::URA3 ura3 his3 
MATa cdc25-mS::URA3 ma3 leu2 
MATa/MATcu cdc25-mS::URA3/cdc25-m5::URA3 ura3/ura3 
his3/ + leu2/ + 
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blotting as described [14). Haploid cdc25-m4 and cdc25-m5 
mutants were obtained after sporulation of the heterozygous 
diploid transformants KM20 and KM24, respectively, and 
homozygous mutant diploids (KM23 and KM26) were obtained 
by crossing haploid mutants with opposite mating types and 
auxotrophic markers. Sporulation efficiency, growth 
parameters and storage carbohydrate content were determined 
as described [14]. 
2.2. Determination of intracellular CAMP 
Growth and sampling of yeast cells were performed as de- 
scribed by Nakafuku et al. [16]. Cells were grown overnight at 
30°C to the stationary phase and were collected by centrifuga- 
tion. After washing twice with water cells were resuspended in 
a buffer containing 10 mM Mes (pH 6.0) and 0.1 mM EDTA 
and were further incubated for 2 h at 30°C under shaking. 
Glucose was added to a final concentration of 25 mM. After in- 
cubation for various periods of time 0.5 ml aliquots were 
transferred from the culture to a test tube containing 0.5 ml of 
10% (w/v) ice-cold trichloroacetic acid and a small amount of 
glass beads (0.5 mm @), and were subsequently frozen in liquid 
Nz. The samples were thawed on ice, and cell breakage was 
achieved by vortexing the tubes for 4 min in 30 s intervals at 
4°C. To eliminate trichloroacetic acid from the extracts the pro- 
cedure of Eraso and Gancedo [17] was used. HCl was added to 
a final concentration of 10 mM, followed by 4 extractions with 
diethyl ether. The residual ether was removed by NZ aspiration, 
the samples were neutralized by addition of 1 M imidazole, and 
the CAMP content was determined using the Amersham 
[‘HIcAMP radioassay kit following the recommended pro- 
cedure. 
Protein concentration was determined by the method of 
Bradford [18] using bovine serum albumin as standard. 
3. RESULTS 
Fig.lA shows the chromosomal map of the 
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CDC25 wild type allele, as determined by genomic 
blotting (data not shown). In a previous study [ 141 
we have described the construction and restriction 
maps of two groups of mutants: in a first group the 
selectable marker genes URA3 or HIS3 were in- 
serted at positions dl or d2 (URA3) or d3 (HIS3), 
resulting in the deletion of 38 (c&25-&) or 88 
(c&25-d2) carboxy-terminal amino acids. The 
disruption at the central d3 position dissects the 
CDC25 gene into two sub-genes, expressing the 
non-essential amino-terminal half (cu domain, see 
protein map of fig.lC) under the control of 
CDC25 promotor, and separately expressing the 
essential carboxy-terminal half (~3 domain) under 
the control of a fortuitous plasmid-encoded ele- 
ment [14]. 
In a second group of mutants the selectable 
marker URA3 was placed at a functionally neutral 
position downstream of the CDC25 gene (fig.lB), 
followed by a tandem repeat of the downstream 
region required for single-step gene replacement. 
Various inframe deletions (m2 - m5) were then in- 
troduced within the cy domain of the coding region, 
removing amino acid residues 114-348 (m4), 
354-876 (m2), 114-876 (m5) or 354-1255 (m3) 
1191. 
All manipulations affecting the Pl domain (in- 
cluding the disruption at d2 and the deletion m3 
shown in fig. 1) turned out to be lethal, whereas the 
deletion of p2, the central disruption (d3) and the 
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Fig.1. (A) Chromosomal restriction map of the wild type CDC25 allele. dl and d2, disruption of the coding region by URA3; d3, 
disruption by HIS3. (B) Map of mutant alleles m2-m5 with deletions indicated. Black bar, coding region; shaded bar, URA3. 
Restriction sites: H, HindIII; S, Safl; h, HpaI; b, BglII; P, PstI; B, BumHI; s, SphI; N, NheI; p, PvuII; X, XbaI. (C) CDC25 protein 
map deduced from DNA sequence data [9,19]. Y, potential N-glycosylation sites (Asn-X-Ser/Thr); black box, potential membrane- 
spanning site. 
deletions within the (Y domain did not significantly 
impair germination and growth in glucose media 
1141. 
The data of fig.2 demonstrate that all non-lethal 
deletions and disruptions of the CDC25 gene have 
a rather striking effect on glucose-induced CAMP 
signaling. The CDC25 wild type diploid strain 
HK3 exhibits a CAMP signal (fig.2A) observed also 
in other S. cerevisiae strains. Typically the starting 
CAMP level of 0.2-0.3 nmol/mg protein rises to a 
maximum of 1.5-2 nmol within the first 45 s after 
glucose addition, and then drops to a final level of 
about 0.5 nmol/mg protein. All mutant strains 
having deletions within the (Y domain (m2, m4, m5) 
fail to produce a CAMP signal upon addition of 
glucose, and they maintain a low CAMP level at or 
below 0.2 nmol/mg protein. 
A completely different effect is observed if the 
carboxy-terminal p2 domain is deleted by inserting 
the URA3 gene at position dl, as shown in fig.2B: 
glucose induces an immediate increase of CAMP 
comparable to that of the parental CDC25 wild 
type strain HK3, but in contrast to the wild type 
CAMP signal the maximum level is maintained or 
only slightly reduced within 6 min after induction. 
The temperature-sensitive mutant cdc25-I pro- 
duces only very weak signals both at permissive 
(25°C) and non-permissive temperature (37”C), as 
shown in fig.2B. The final CAMP level (around 
. 
=====-a- 
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Fig.2. Glucose-induced CAMP signaling in CDC25 wild type 
and mutant strains. Glucose was added at zero time to starved 
cells. (A) Strain HK3 (CDC25, M), KM18 (c&25-m2; 
G--o), KM2lb (c&25+&, U), KM25b (c&25-m5, 
ti). (B) KM4 (c&25-&, o---o), KM10 (c&25-d3, 
M), KLlb (c&25-1, U) grown at 25°C. or shifted to 
37°C for 5 h (ti). 
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0.2 nmol/mg protein in cells grown at 25°C) is 
already much lower than the wild type level, and is 
further reduced after arrest at 37°C. 
4. DISCUSSION 
Our data clearly demonstrate that the CDC25 
gene product is involved in glucose-induced CAMP 
signaling, and that manipulations at three opera- 
tionally defined domains of the CDC25, protein 
have quite different effects on glucose signal 
transduction. A previous study has shown that 
these domains differentially control also other 
phenotypical parameters, such as growth on 
fermentable and non-fermentable carbon sources, 
mobilization of storage carbohydrates and 
sporulation [14]. Deletions within the amino- 
terminal half (cu domain) do not affect viability 
and growth in glucose media, but completely 
abolish the glucose-induced transient rise of 
CAMP, indicating that a functional glucose signal 
transduction chain is not a prerequisite for mitotic 
growth in glucose media. The same group of 
mutants (c&25 alleles m2, m4 and m5, see protein 
map of fig.lC) fails to grow on non-fermentable 
carbon sources, to sporulate (if in a diploid state) 
and to mobilize the storage carbohydrates 
trehalose and glycogen. Therefore, the CY domain 
appears to be required not only for glucose signal 
transduction, but also for starvation response and 
initiation of meiosis, probably by sensing the nutri- 
tional environment. 
The main part of the carboxy-terminal half da1 
domain) of the CDC25 protein is essential for 
viability (germination and growth in glucose 
media), because deletions and disruptions af- 
fecting the pl domain (such as m3 and d2, see 
fig. 1) are lethal in strains having a wild type CAMP 
control chain [14]. Furthermore, the conditional- 
lethal cdc25-I mutation [8] is located within this 
domain, because multicopy plasmids containing 
the pl fragment complement the temperature- 
sensitive lesion [9,10,15,19,20]. Our data (fig.2B) 
demonstrate that the ,~31 domain is also involved in 
glucose signal transduction, since the cdc25-I 
mutation strongly reduces the CAMP signal, even 
at permissive temperature. 
The ,~31 domain is required for the activation of 
adenylate cyclase via activation of ras proteins, 
probably by catalyzing the GDP-GTP exchange on 
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rash or ras2 [9,12], and at least one functional ras 
gene is required for glucose-induced CAMP signal- 
ing [a]. The p2 domain is not required for growth 
on fermentable and non-fermentable carbon 
sources and for storage carbohydrate mobiliza- 
tion, but for sporulation [14]. The data of fig.2B 
demonstrate that the p2 domain is dispensable for 
the glucose-induced hyperactivation of ras- 
adenylate cyclase, but is required for down- 
regulating adenylate cyclase. This finding im- 
mediately supports the recently proposed feedback 
control loop of the CAMP signaling system in yeast 
[l 11. One of the components of the CAMP control 
chain, the ras2 protein, is downregulated by 
phosphorylation through the catalytic subunit of 
CAMP-dependent protein kinase [21], and a 
similar feedback loop might operate to 
downregulate the CDC25 protein, in analogy to 
the homologous desensitization of hormone recep- 
tors [22,23]. The most straightforward idea would 
be a downregulation by CAMP-dependent 
phosphorylation of a p2 threonine or serine 
residue, although a more indirect role of p2 is also 
possible. A special comment is deserved to explain 
the phenotype of the cdc25-d3 mutant, where the 
two halves of the gene are separately expressed as 
CY and fl subunits. Obviously this mutant shares all 
properties with mutants having deletions in the CY 
domain (m2, m4, m5), including the loss of 
glucose-induced CAMP signaling and starvation 
response, although the a domain is expressed 
under the control of the CDC25 promotor [14]. 
Recent complementation experiments with 
heterozygous cdc25 mutant diploids favour the 
idea that the a domain has to be attached to a fll 
region including a potential membrane-spanning 
domain, in order to be carried to its functional site. 
Since the CDC25 gene product is the most 
upstream function known to be involved in the ac- 
tivation of adenylate cyclase [9, lo] and in the deci- 
sion between mitosis and meiosis [13,14], it is 
tempting to consider the CDC25 protein as a 
receptor-like transmembrane protein having an ex- 
tracellular nutrient-sensing domain or subunit. 
On the other hand, our data do not rule out an 
intracellular glucose-sensing function of the 
CDC25 protein. The CAMP signal would then be 
triggered by other glucose-sensing surface pro- 
teins, such as hexose transporters [5,24]. However, 
CAMP signaling appears to be independent of the 
Volume 242, number 2 FEBS LETTERS January 1989 
SNF3 gene function [6] encoding a hexokinase- 
dependent high affinity glucose transporter 
125,261, and is not affected by disrupting a recently 
cloned gene controlling low affinity glucose uptake 
(our unpublished data). Therefore, the relation 
between glucose transport and glucose sensing re- 
mains to be established. 
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